Cigna rolls out new plan to fully cover multi-million dollar gene therapies
A screen displays the logo fro Cigna Corp. on the floor at the New York Stock Exchange (NYSE) in New York, U.S., July 16, 2019. REUTERS/Brendan McDermid (Reuters) – Health…
Bluebird prices gene therapy at 1.58 million euros over 5 years
(Reuters) – Bluebird bio Inc on Friday set a price for its gene therapy, Zynteglo, at 1.58 million euros ($1.78 million) over five years, after winning conditional approval in Europe…